As the important cellular and molecular mechanisms contributing to heart failure, the US Food and Drug Administration has approved Gal-3 as a soluble biomarker for cardiac fibrosis to detect cardiac tissue remodeling [94]. The gene discussed is LGALS3; the disease is heart failure.